ESR1 and breast carcinoma: Among them, ErbB2 (or HER-2/neu) amplification strongly correlates with steroid receptor negative tumors [5,6], and amplification of AIB1(amplified in breast cancer 1) gene is prevalent in estrogen receptor (ER) positive tumors [7,8].